Archives of Medical Research
Volume 41, Issue 4 , Pages 302-308 , May 2010

HbA1c for the Diagnosis of Diabetes Mellitus in a Developing Country. A Position Article

Received 16 April 2010 ,Accepted 24 May 2010.

References 

  1. The International Expert Committee Report on the Role of the A1C Assay in the diagnosis of Diabetes. Diabetes Care. 2009;32:1327–1334
  2. American Diabetes Association . Diagnosis Criteria for Diabetes Mellitus. Diagnosis and Classification of Diabetes Mellitus. Diabetes Care. 2010;33(suppl 1):S62–S69
  3. American Diabetes Association . Screening for type 2 diabetes (Clinical Practice Recommendations 2004: Position Statement). Diabetes Care. 2004;27:S11–S14
  4. Vistisen D, Colagiuri S, Borch-Johnsen K. The DETECT-2 Collaboration. Bimodal distribution of glucose is not universally useful for diagnosing diabetes. Diabetes Care. 2009;32:397–403
  5. Bennett AL, Guop M, Dharmage SC. HbA1C as a screening tool for detection of type 2 diabetes: a systematic review. Diabet Med. 2007;24:333–343
  6. Sabanayagam C, Liew G, Tai ES, et al. Relationship between glycated haemoglobin and microvascular complications: is there a natural cut-off point for the diagnosis of diabetes?. Diabetologia. 2009;52:1279–1289
  7. Selvin E, Steffes MW, Zhu H, et al. Glycated hemoglobin, diabetes, and cardiovascular risk in nondiabetic adults. N Engl J Med. 2010;362:800–811
  8. The DECODE Study Group . Is the current definition for diabetes relevant to mortality risk from all causes and cardiovascular and non-cardiovascular diseases. Diabetes Care. 2003;26:688–696
  9. Goldstein DE, Little RR, Lorenz RA, et al. Global harmonization of hemoglobin A1c. Clin Chem. 2005;51:681–683
  10. Lenters-Westra E, Slingerland RJ. Six out of eight hemoglobin A1c point-of care instruments do not meet the generally accepted analytical performance criteria. Clin Chem. 2010;56:44–52
  11. Amquist H, Wallensteen M, Jeppsson JO. Standardization of long-term glucose measurements established. Lakartidningen. 1997;50:4789–4790
  12. Peters AL, Davidson MB, Schigrer DL, et al. A clinical approach for the diagnosis of diabetes mellitus. An analysis using glycosylated hemoglobin levels. JAMA. 1996;276:1246–1252
  13. Faerch A, Borch-Johnsen K, Vaag A, et al. Sex differences in glucose levels: a consequence of physiology or methodological convenience? The Inter99 study. Diabetologia. 2010;53:858–865
  14. Shima K, Endo J, Oimoni Y, et al. A report of the committee on an inter-laboratory standardization of HbA1C determination. The Japan Diabetes Society. J Jpn Diabetes Soc. 1994;37:855–864
  15. García-Alcalá H, Ruiz-Argüelles A, Cedillo-Carvallo B. Effect of the method to measure levels of glycated hemoglobin on individual clinical decisions comparison of an immunoassay with high-performance liquid chromatography. Am J Clin Pathol. 2009;132:332–335
  16. Ezenwaka C, Jones-LeCointe A, Nwagbara E, et al. Anaemia and kidney dysfunction in Caribbean type 2 diabetic patients. Cardiovasc Diabetol. 2008;7:25–31
  17. Buell C, Kermah D, Davidson MB. Utility of A1C for diabetes screening in the 1999 2004 NHANES population. Diabetes Care. 2007;30:2233–2235
  18. Ravi Kumar P, Bhansali A, Ravikiran M, et al. Utility of glycated hemoglobin in diagnosing type 2 diabetes mellitus: a community-based study. J Clin Endocrinol Metab. Published ahead of print April 6, 2010 (doi:10.1210/jc.2009–2433).
  19. Saudek CD, Herman WH, Sacks DB, et al. A new look at screening and diagnosing diabetes mellitus. J Clin Endocrinol Metab. 2008;93:2447–2453
  20. Herman WH, Fajans SS. Hemoglobin A1c for the diagnosis of diabetes: practical considerations. Pol Arch Med Wewn. 2010;120:37–41
  21. Kramer CK, Araneta MR, Barrett-Connor E. A1C and diabetes diagnosis: The Rancho Bernardo Study. Diabetes Care. 2010;33:101–103
  22. Carson A, Reynolds K, Fonseca V, et al. Comparison of A1C and fasting glucose criteria to diagnose diabetes among U.S. adults. Diabetes Care. 2010;33:95–97
  23. Lu X, Walker K, O'Dea K, et al. A1C for screening and diagnosis of type 2 diabetes in routine clinical practice. Diabetes Care. 2010;33:817–819
  24. Herman WH, Dungan KM, Wolffenbuttel BHR, et al. Racial and ethnic differences in mean glucose, hemoglobin A1c, and 1,5 anhydroglucitol in over 2000 patients with type 2 diabetes. J Clin Endocrinol Metab. 2009;94:1689–1694
  25. Christensen DL, Witte DR, Kduka L, et al. Moving to an A1c-based diagnosis of diabetes has a different impact on prevalence in different ethnic groups. Diabetes Care. 2010;33:580–582
  26. Anand SS, Razak F, Vuksan V, et al. Diagnostic strategies to detect glucose intolerance in a multiethnic population. Diabetes Care. 2003;26:290–229
  27. Cowie C, Rust K, Byrd-Holt D, et al. Prevalence of diabetes and high risk for diabetes using A1C criteria in the U.S. population in 1988–2006. Diabetes Care. 2010;33:562–568
  28. Herman WH, Ma Y, Uwaifo G, et al. Diabetes Prevention Program Research Group Differences in A1C by race and ethnicity among patients with impaired glucose tolerance in the Diabetes Prevention Program. Diabetes Care. 2007;30:2453–2457
  29. Kim C, McKeever K, Herman WH, et al. Association between iron deficiency spherocytosis and HbA1C levels among adults without diabetes in the National Health and Nutrition Examination Survey, 1999–2006. Diabetes Care. 2010;33:780–785
  30. El-Agouza I, Abu SA, Syrdah M. The effect of iron-deficiency anaemia on the glycosylated hemoglobin subtypes: possible consequences for clinical diagnosis. Clin Lab Haematol. 2002;24:285–289
  31. Pani LN, Korenda L, Meigs JM, et al. Effect of aging on A1C levels in individuals without diabetes. Diabetes Care. 2008;31:1991–1996
  32. Krovesdy CP, Sharma K, Kalantar-Zadeh K. Glycemic control in diabetic CKD patients: where do we stand?. Am J Kidney Dis. 2008;52:766–777
  33. Gomez-Perez FJ, Valles-Sanchez VE, Lopez-Alvarenga JC, et al. Vitamin E modifies neither fructosamine nor HbA1c levels in poorly controlled diabetes. Rev Invest Clin. 1996;48:421–424
  34. Gomez-Perez FJ, Aguilar-Salinas CA, López-Alvarenga JC, et al. Lack of agreement between the World Health Organization category of impaired glucose tolerance and the American Diabetes Association category of impaired fasting glucose. Diabetes Care. 1998;21:1886–1888
  35. Ko GTC, Chan JCN, Yeung VTF, et al. Combined use of fasting plasma glucose concentration and HbA1C or fructosamine predicts the likelihood of having diabetes in high risk subjects. Diabetes Care. 1998;21:1221–1225

PII: S0188-4409(10)00133-5

doi: 10.1016/j.arcmed.2010.05.007

Archives of Medical Research
Volume 41, Issue 4 , Pages 302-308 , May 2010

Article Tools